# S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery

> **NCT00002921** · PHASE2 · TERMINATED · sponsor: **SWOG Cancer Research Network** · enrollment: 13 (actual)

## Conditions studied

- Adrenocortical Carcinoma

## Interventions

- **DRUG:** suramin
- **DRUG:** therapeutic hydrocortisone

## Key facts

- **NCT ID:** NCT00002921
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1997-03
- **Primary completion:** 2004-01
- **Final completion:** 2004-01
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Permanently Closed Due to Lack of Accrual
- **Last updated:** 2012-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002921, "S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00002921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*